Meredith (Westerlund) Schneider is a seasoned professional in consulting and biotechnology, currently serving as Principal Consultant at Graham-Pelton since August 2021, following a role as Senior Consultant. Prior experience includes Chief Operating Officer at Ichosia Biotechnology, Inc., where efforts focused on developing Erythrosyn, a revolutionary blood product addressing global blood shortages through advanced genetic engineering and stem cell techniques. Previously, Meredith held various positions at George Washington University, culminating as Associate Director of Central Initiatives, and served as Development Manager and Events Coordinator at the Leadership Center for Excellence. Early career experiences include internships and assistant roles at the University of Michigan and Amnesty International. Educational qualifications include an MBA in Management Leadership and Nonprofit Management from The George Washington University School of Business and a Bachelor of Arts in Political Science and Scandinavian Studies from the University of Michigan.